Patent · US Active

Cathepsin-binding compounds bound to a carrier and their diagnostic use

US9827337B2 · kind B2 · utility

2Cited by

2References

3Claims

0Family size

Assignee

J. Stefan Institute · SI

Inventors

Olga Vasiljeva · Cupertino, US
Georgy Mikhaylov · Almaty, KZ
Boris Turk · Škofljica, SI
Norbert Schaschke · Hersbruck, DE

Key dates

Filing date	Jun 22, 2012
Grant date	Nov 28, 2017
Priority date	—
Expiry date	Aug 18, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to Cathepsin-binding compounds bound to a carrier comprising a diagnostic moiety, for use in the diagnosis of inflammatory diseases, and/or for use in the diagnosis of neoplastic diseases, wherein the Cathepsin-binding compound binds to inflammatory cells of the tumour stroma. The invention also relates to Cathepsin B-targeting compounds and Cathepsin B-binding and liposome-binding compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.